Literature DB >> 15169676

Net absorption of IgG via FcRn-mediated transcytosis across rat alveolar epithelial cell monolayers.

Kwang-Jin Kim1, Tamer E Fandy, Vincent H L Lee, David K Ann, Zea Borok, Edward D Crandall.   

Abstract

We characterized immunoglobulin G (IgG) transport across rat alveolar epithelial cell monolayers cultured on permeable supports. Unidirectional fluxes of biotin-labeled rat IgG (biot-rIgG) were measured in the apical-to-basolateral (ab) and opposite (ba) directions as functions of [rIgG] in upstream fluids at 37 and 4 degrees C. We explored specificity of IgG transport by measuring fluxes in the presence of excess Fc, Fab, F(ab')2, or chicken Ig (IgY). Expression of the IgG receptor FcRn and the effects of dexamethasone on FcRn expression and biot-rIgG fluxes were determined. Results show that ab flux of biot-rIgG is about fivefold greater than ba flux at an upstream concentration of 25 nM biot-rIgG at 37 degrees C. Both ab and ba fluxes of rIgG saturate, resulting in net absorption with half-maximal concentration and maximal flow of 7.1 nM and 1.3 fmol.cm(-2).h(-1). At 4 degrees C, both ab and ba fluxes significantly decrease, nearly collapsing net absorption. The presence of excess unlabeled Fc [but not Fab, F(ab')2, or IgY] significantly reduces biot-rIgG fluxes. RT-PCR demonstrates expression of alpha- and beta-subunits of rat FcRn. Northern analysis further confirms the presence of alpha-subunit of rat FcRn mRNA of approximately 1.6 kb. Dexamethasone exposure for 72 h decreases the steady-state level of mRNA for rat FcRn alpha-subunit and the ab (but not ba) flux of biot-rIgG. These data indicate that IgG transport across alveolar epithelium takes place via regulable FcRn-mediated transcytosis, which may play an important role in alveolar homeostasis in health and disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15169676     DOI: 10.1152/ajplung.00121.2004

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  21 in total

1.  Expression and transport functionality of FcRn within rat alveolar epithelium: a study in primary cell culture and in the isolated perfused lung.

Authors:  Masahiro Sakagami; Yadollah Omidi; Lee Campbell; Lana E Kandalaft; Christopher J Morris; Jaleh Barar; Mark Gumbleton
Journal:  Pharm Res       Date:  2006-01-01       Impact factor: 4.200

Review 2.  Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn.

Authors:  Kristi Baker; Shuo-Wang Qiao; Timothy Kuo; Kanna Kobayashi; Masaru Yoshida; Wayne I Lencer; Richard S Blumberg
Journal:  Semin Immunopathol       Date:  2009-06-03       Impact factor: 9.623

3.  Characterization of protein factor(s) in rat bronchoalveolar lavage fluid that enhance insulin transport via transcytosis across primary rat alveolar epithelial cell monolayers.

Authors:  Rana Bahhady; Kwang-Jin Kim; Zea Borok; Edward D Crandall; Wei-Chiang Shen
Journal:  Eur J Pharm Biopharm       Date:  2008-02-06       Impact factor: 5.571

4.  Prevention of the murine model of biliary atresia after live rotavirus vaccination of dams.

Authors:  Alexander J Bondoc; Mubeen A Jafri; Bryan Donnelly; Sujit K Mohanty; Monica M McNeal; Richard L Ward; Greg M Tiao
Journal:  J Pediatr Surg       Date:  2009-08       Impact factor: 2.545

Review 5.  Chapter 4: Multitasking by exploitation of intracellular transport functions the many faces of FcRn.

Authors:  E Sally Ward; Raimund J Ober
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

Review 6.  The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases.

Authors:  Alina Sesarman; Gestur Vidarsson; Cassian Sitaru
Journal:  Cell Mol Life Sci       Date:  2010-03-09       Impact factor: 9.261

Review 7.  Cross-presentation of IgG-containing immune complexes.

Authors:  Kristi Baker; Timo Rath; Wayne I Lencer; Edda Fiebiger; Richard S Blumberg
Journal:  Cell Mol Life Sci       Date:  2012-07-31       Impact factor: 9.261

8.  Pulmonary pharmacodynamics of an anti-GM-CSFRα antibody enables therapeutic dosing that limits exposure in the lung.

Authors:  Jamie Campbell; Josquin Nys; Laura Eghobamien; E Suzanne Cohen; Matthew J Robinson; Matthew A Sleeman
Journal:  MAbs       Date:  2016-08-12       Impact factor: 5.857

Review 9.  Neonatal Fc receptor: from immunity to therapeutics.

Authors:  Timothy T Kuo; Kristi Baker; Masaru Yoshida; Shuo-Wang Qiao; Victoria G Aveson; Wayne I Lencer; Richard S Blumberg
Journal:  J Clin Immunol       Date:  2010-10-01       Impact factor: 8.317

10.  FcRn receptor-mediated pharmacokinetics of therapeutic IgG in the eye.

Authors:  Hyuncheol Kim; Shaun B Robinson; Karl G Csaky
Journal:  Mol Vis       Date:  2009-12-16       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.